As of 2025-12-18, the Relative Valuation of THC Biomed Intl Ltd (THC.CN) is (0.24) CAD. This relative valuation is based on P/E multiples. With the latest stock price at 0.02 CAD, the upside of THC Biomed Intl Ltd based on Relative Valuation is -1320.5%.
The range of the Relative Valuation is (0.21) - (0.41) CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 4.3x - 9.2x | 5.5x |
| Forward P/E multiples | 4.8x - 9.2x | 5.4x |
| Fair Price | (0.21) - (0.41) | (0.24) |
| Upside | -1166.0% - -2151.4% | -1320.5% |
| Date | P/E |